| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/29/2006 | US20060140954 Novel human protein kinases and protein kinase-like enzymes |
| 06/29/2006 | US20060140953 Systems and methods for treating human inflammatory and proliferative diseases and wounds, with UCP and/or FAS antibody or other inhibitor, optionally with a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor |
| 06/29/2006 | US20060140952 Tumour necrosis factor binding ligands |
| 06/29/2006 | US20060140951 Tumour necrosis factor binding ligands |
| 06/29/2006 | US20060140949 IgG4 constant region; Fab' fragment; antibody or antigen binding fragment inhibits binding of A2 or cA2 to human TNF- alpha , and binds to a neutralizing epitope of human TNF- alpha; immunoassays and immunotherapeutic agent |
| 06/29/2006 | US20060140948 Sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's) |
| 06/29/2006 | US20060140946 Anti-TNF chimeric antibody fragments |
| 06/29/2006 | US20060140945 Nephropathy-associated gene |
| 06/29/2006 | US20060140944 Novel polypeptides involved in immune response |
| 06/29/2006 | US20060140940 Anti-hgf-r antibodies and their use |
| 06/29/2006 | US20060140939 Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury |
| 06/29/2006 | US20060140938 peroxisome proliferator activated receptor |
| 06/29/2006 | US20060140937 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/29/2006 | US20060140936 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 06/29/2006 | US20060140935 Platlet glycoprotein Ib alpha fusion polypeptides and methods of use thereof |
| 06/29/2006 | US20060140933 Compositions and methods for treating rage-associated disorders |
| 06/29/2006 | US20060140932 Human il-1 beta antagonists |
| 06/29/2006 | US20060140931 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 06/29/2006 | US20060140920 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain |
| 06/29/2006 | US20060140919 Methods for selectively stimulating proliferation of T cells |
| 06/29/2006 | US20060140858 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 06/29/2006 | CA2799802A1 Antibodies directed to angiopoietin-2 and uses thereof |
| 06/29/2006 | CA2601700A1 Protein phosphorylation in egfr-signaling pathways |
| 06/29/2006 | CA2593956A1 Agents inhibiting the cathelin-like protein cap18/ll-37 |
| 06/29/2006 | CA2592390A1 Methods for producing soluble multi-membrane-spanning proteins |
| 06/29/2006 | CA2592249A1 Binding proteins specific for human matriptase |
| 06/29/2006 | CA2592201A1 Neuromedin s and the use thereof |
| 06/29/2006 | CA2592153A1 Resistance genes |
| 06/29/2006 | CA2591813A1 Anti-il-12 antibodies, epitopes, compositions, methods and uses |
| 06/29/2006 | CA2591786A1 Prevention of thrombus formation and/or stabilization |
| 06/29/2006 | CA2591665A1 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 06/29/2006 | CA2591510A1 Group b streptococcus |
| 06/29/2006 | CA2591304A1 Compositions and methods relating to anti-igf-1 receptor antibodies |
| 06/29/2006 | CA2590936A1 Combination therapy for b cell disorders |
| 06/29/2006 | CA2590471A1 Combination treatment for multiple sclerosis |
| 06/29/2006 | CA2590461A1 Bcma polypeptides and uses thereof |
| 06/28/2006 | EP1674869A1 Method of examining colon cancer and colon adenoma |
| 06/28/2006 | EP1674575A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/28/2006 | EP1674564A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor |
| 06/28/2006 | EP1674480A1 Antibody recognizing tgf-beta activation controlling region section |
| 06/28/2006 | EP1674479A1 Modulation of Fc Gamma receptors for optimizing immunotherapy |
| 06/28/2006 | EP1674111A1 Anti-glypican 3 antibody |
| 06/28/2006 | EP1674108A2 Osteoporosis treatment |
| 06/28/2006 | EP1673633A1 Method and device for detecting feline immunodeficiency virus |
| 06/28/2006 | EP1673399A2 Detecting and profiling molecular complexes |
| 06/28/2006 | EP1673398A1 Multispecific deimmunized cd3-binders |
| 06/28/2006 | EP1673397A2 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies |
| 06/28/2006 | EP1673396A1 Use of antibodies for reducing the biological effectiveness of il-6 |
| 06/28/2006 | EP1673395A1 Alteration of fc-fusion protein serum half-lives by mutagenesis of positions 250, 314 and/or 428 of the heavy chain constant region of ig |
| 06/28/2006 | EP1673394A2 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent |
| 06/28/2006 | EP1673393A2 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity |
| 06/28/2006 | EP1673392A2 Antibodies having a mutated amino acid residue at position 268 (ch2 region) in constant regions |
| 06/28/2006 | EP1673390A2 Ztnfr14, A TUMOR NECROSIS FACTOR RECEPTOR |
| 06/28/2006 | EP1673101A1 Lim2 inhibitors of lmo2 |
| 06/28/2006 | EP1597370B1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 06/28/2006 | EP1556403A4 Multimeric protein engineering |
| 06/28/2006 | EP1360499B1 Determination of cytosolic nadp-dependent malate dehydrogenase isoenzyme |
| 06/28/2006 | EP1268783B1 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 06/28/2006 | EP1261641B1 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 06/28/2006 | EP1062237B1 Ribonucleotide polypeptides containing metal |
| 06/28/2006 | EP1060251B1 Phosphodiesterase 10 |
| 06/28/2006 | EP0935604B1 Magnetically activated cell sorting for production of proteins |
| 06/28/2006 | EP0897426B1 Matrix metalloprotease |
| 06/28/2006 | EP0895543B1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 06/28/2006 | EP0882799B1 Anti-human vegf receptor flt-1 monoclonal antibody |
| 06/28/2006 | EP0787138B1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 06/28/2006 | EP0727490B1 Human-origin prostacyclin synthase |
| 06/28/2006 | EP0712414B1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences |
| 06/28/2006 | CN1795388A Diagnostic kit for liver cirrhosis comprising an antibody specific for human protooncogenic protein |
| 06/28/2006 | CN1795387A Proteomic analysis of biological fluids |
| 06/28/2006 | CN1795268A Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific b lymphocyte and method for manufacturing monoclonal antibody |
| 06/28/2006 | CN1795208A Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 06/28/2006 | CN1795207A Anti-amyloid antibodies, compositions, methods and uses |
| 06/28/2006 | CN1795205A Spex compositions and methods of use |
| 06/28/2006 | CN1795010A Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 06/28/2006 | CN1795009A Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 06/28/2006 | CN1793369A Recombined 3-type parainfluenza viruse nuclelc shell protein and process for preparing antibody thereof |
| 06/28/2006 | CN1793362A Recombined human A3 type influenza viruse stromatin and its preparation process and application thereof |
| 06/28/2006 | CN1261579C Hybrid proteins which form heterodimers |
| 06/28/2006 | CN1261577C Method for modifying plant morphology, biochemistry and physiology |
| 06/28/2006 | CN1261566C Method for preparing non-receptor type tyrosine protein kinase Syk |
| 06/28/2006 | CN1261455C Recombinant humanized anti-hepatitis B surface antigen (HBsAg) Fab antibody and its preparation method |
| 06/28/2006 | CN1261454C Preparation of anti-caries bacteria IgY, and anti-caries composition |
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/27/2006 | US7067642 expression vectors; transformed cells; useful in diagnosing and treating conditions including cancer |
| 06/27/2006 | US7067639 Method to provide bacterial ghosts provided with antigens |
| 06/27/2006 | US7067638 detection kit for discriminating genogroup of SRSVs comprising all polyclonal antibodies against SRSV-related virus constituting peptides; makes it possible to detect most SRSV-related viruses and further to distinguish their serotypes and genogroups. |
| 06/27/2006 | US7067637 having mitogenic and/or differentiation-inductive, e.g. osteo-inductive potential, which is coded by DNA sequences coding for new members of the TGF- beta protein family |
| 06/27/2006 | US7067636 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents |
| 06/27/2006 | US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines |
| 06/27/2006 | US7067634 Method for diagnosing or monitoring carbohydrate metabolism disorders |
| 06/27/2006 | US7067629 Sodium channel in dorsal root ganglia |
| 06/27/2006 | US7067487 Amino acid sequence having homology with amino acid position 194 to 220 in a pestiviral Erns protein RNase, from 59-88 in a L3 loop of a cytotoxic RNase of a ribosome-inactivating protein, or 187- 223 in respiratory syncytial virus |
| 06/27/2006 | US7067486 Acetylcholinesterase-derived peptides and uses thereof |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067318 Methods for transfecting T cells |
| 06/27/2006 | US7067314 Monoclonal antibody, its immunoreactive fragment and hybridoma |
| 06/27/2006 | US7067313 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 06/27/2006 | US7067308 Vector for genetically modifying non-human animals |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |